Why Are Clinicians Not Embracing the Results from Pivotal Clinical Trials in Severe Sepsis? A Bayesian Analysis
Andre C. Kalil, Junfeng Sun · 2008
Read Why Are Clinicians Not Embracing the Results from Pivotal Clinical Trials in Severe Sepsis? A Bayesian Analysis by Andre C. Kalil, Junfeng Sun (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0002291.txt.
Description
Andre Kalil and Junfeng Sun asked why doctors have been slow to adopt five trial-proven treatments for severe sepsis, in a 2008 PLOS ONE paper. Five pivotal trials had shown lower mortality with intensive insulin therapy, activated protein C, low-tidal volume ventilation, low-dose steroids, and early goal-directed therapy. Expert guidelines recommended all five, yet uptake in practice lagged.
The authors used a Bayesian analysis, which weighs how strong each trial's evidence really is. Their reading helps explain clinician caution: some celebrated results rest on single trials with fragile statistics. The paper is a lesson in reading landmark trials with a cooler head.
Catalog record
| CREATOR | Andre C. Kalil, Junfeng Sun |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002291